GNFTF
Price:
$4.14
Market Cap:
$228.97M
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic ...[Read more]
Industry
Biotechnology
IPO Date
2014-01-27
Stock Exchange
OTC
Ticker
GNFTF
According to Genfit S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 260.37M. This represents a change of 46.71% compared to the average of 177.47M of the last 4 quarters.
The mean historical Enterprise Value of Genfit S.A. over the last ten years is 346.58M. The current 260.37M Enterprise Value has changed 7.41% with respect to the historical average. Over the past ten years (40 quarters), GNFTF's Enterprise Value was at its highest in in the June 2017 quarter at 814.29M. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.
Average
346.58M
Median
288.74M
Minimum
8.58M
Maximum
729.62M
Discovering the peaks and valleys of Genfit S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.49%
Maximum Annual Enterprise Value = 729.62M
Minimum Annual Increase = -94.95%
Minimum Annual Enterprise Value = 8.58M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 158.17M | -6.27% |
| 2023 | 168.74M | 23.73% |
| 2022 | 136.38M | 1.49% |
| 2021 | 8.58M | -94.95% |
| 2020 | 169.79M | -69.67% |
| 2019 | 559.71M | 11.25% |
| 2018 | 503.10M | -19.38% |
| 2017 | 624.06M | 53.07% |
| 2016 | 407.68M | -44.12% |
| 2015 | 729.62M | -2.11% |
The current Enterprise Value of Genfit S.A. (GNFTF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
154.43M
5-year avg
128.33M
10-year avg
346.58M
Genfit S.A.’s Enterprise Value is greater than Santhera Pharmaceuticals Holding AG (217.04M), less than JW (Cayman) Therapeutics Co. Ltd (886.52M), less than NervGen Pharma Corp. (438.78M), greater than Brii Biosciences Limited (-453427127.87), greater than NDT Pharmaceuticals Inc. (158.40M), greater than Silence Therapeutics plc (241.81M), greater than Molecular Partners AG (46.83M), greater than Transgene S.A. (137.92M), greater than Innate Pharma S.A. (128.18M), greater than Botanix Pharmaceuticals Limited (172.49M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 217.04M | $172.71M | |
| 886.52M | $150.63M | |
| 438.78M | $329.05M | |
| -453427127.87 | $173.42M | |
| 158.40M | $158.40M | |
| 241.81M | $255.06M | |
| 46.83M | $134.64M | |
| 137.92M | $132.89M | |
| 128.18M | $183.43M | |
| 172.49M | $150.41M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genfit S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genfit S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Genfit S.A.'s Enterprise Value?
What is the highest Enterprise Value for Genfit S.A. (GNFTF)?
What is the 3-year average Enterprise Value for Genfit S.A. (GNFTF)?
What is the 5-year average Enterprise Value for Genfit S.A. (GNFTF)?
How does the current Enterprise Value for Genfit S.A. (GNFTF) compare to its historical average?